Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPM1B | O75688 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18286763 | 1.00 | PPM1B (0.31) | PPM1BPTPN1PPP1CC | |
| SCHEMBL14307892 | 1.00 | PPM1B (0.31) | PPM1BPTPN1PPP1CC | |
| SCHEMBL13488608 | 1.00 | PPM1B (0.31) | PPM1BPTPN1PPP1CC | |
| SCHEMBL686441 | 0.93 | PPM1B (0.30) | PPM1BPTPN1PPP1CC | |
| SCHEMBL13075370 | 0.93 | PPM1B (0.30) | PPM1BPTPN1PPP1CC | |
| SCHEMBL18376026 | 0.93 | TP53 (0.32) | — | |
| SCHEMBL14163658 | 0.91 | — | — | |
| SCHEMBL14619377 | 0.90 | PPM1B (0.33) | PPM1BPTPN1PPP1CC | |
| SCHEMBL11981808 | 0.89 | PPM1B (0.31) | PPM1BPTPN1PPP1CC | |
| SCHEMBL13310909 | 0.86 | EPHX2 (0.33) | PPM1BPTPN1PPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112105671-A | Cycloaliphatic amines used in epoxy formulations: novel curing agents for epoxy systems | 赢创运营有限公司 | 2020-12-18 | — | — | CN | claimed |
| US-20230213857-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING RADICAL TRAPPING AGENT | NISSAN CHEMICAL CORPORATION (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20170327744-A1 | LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME | JNC CORP (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20170321115-A1 | WAVELENGTH CONVERSION MEMBER, BACKLIGHT UNIT INCLUDING WAVELENGTH CONVERSION MEMBER, LIQUID CRYSTAL DISPLAY DEVICE, AND METHOD OF MANUFACTURING WAVELENGTH CONVERSION MEMBER | FUJIFILM CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170321116-A1 | WAVELENGTH CONVERSION MEMBER, BACKLIGHT UNIT INCLUDING WAVELENGTH CONVERSION MEMBER, LIQUID CRYSTAL DISPLAY DEVICE, AND METHOD OF MANUFACTURING WAVELENGTH CONVERSION MEMBER | FUJIFILM CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| US-9796927-B2 | Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layers, liquid crystal alignment layers and liquid crystal display devices using the same | JNC CORPORATION (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20170198149-A1 | WAVELENGTH CONVERSION MEMBER, BACKLIGHT UNIT, LIQUID CRYSTAL DISPLAY DEVICE, QUANTUM DOT-CONTAINING POLYMERIZABLE COMPOSITION, AND MANUFACTURING METHOD OF WAVELENGTH CONVERSION MEMBER | FUJIFILM CORPORATION (JP) | 2017-07-13 | — | — | US | disclosed |
| US-20170174711-A1 | ACID GENERATOR AND COMPOSITION | TOYO GOSEI CO., LTD. (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20170173847-A1 | Thermoforming of Dynamic Cross-Linked Polymer Compositions | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-22 | — | — | US | disclosed |
| US-9685597-B2 | Curable composition for sealing optical semiconductor | DAICEL CORPORATION (JP) | 2017-06-20 | — | — | US | disclosed |
| US-20070077770-A1 | Etching technique to planarize a multi-layer structure | MOLECULAR IMPRINTS, INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070077763-A1 | Deposition technique to planarize a multi-layer structure | MOLECULAR IMPRINTS, INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070072105-A1 | TONERS AND PROCESSES THEREOF | XEROX CORPORATION | 2007-03-29 | — | — | US | disclosed |
| US-20070065608-A1 | Metal containers having an easily openable end and method of manufacturing the same | VALSPAR SOURCING, INC. (US) | 2007-03-22 | — | — | US | disclosed |
| US-7183363-B2 | Thermally conductive casting compound | ROBERT BOSCH GMBH (DE) | 2007-02-27 | — | — | US | disclosed |
| US-20070042275-A1 | Composition for optical recording, optical recording medium, and production method thereof | FUJI PHOTO FILM CO., LTD. | 2007-02-22 | — | — | US | disclosed |
| US-20070031759-A1 | Radiation curable polymer films having improved laser ablation properties and radiation curable sensitizers therefor | NDSU RESEARCH FOUNDATION | 2007-02-08 | — | — | US | disclosed |
| US-7169446-B2 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20070020555-A1 | Photosensitive composition, photosensitive lithography plate and method for producing lithography plate | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20070004849-A1 | Method for the preliminary treatment of cellulose-containing textile | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174711-A1 | ACID GENERATOR AND COMPOSITION | ARFGAP1, ASIC1, ARHGEF1 | PPM1B 3418/4885PTPN1 4332/4885PPP1CC 4377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.